Bristol-Myers Squibb (BMY)

AI Score

Unlock

49.02

-0.21 (-0.43%)

At close: Apr 17, 2025, 3:59 PM

Bristol-Myers Squibb Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	10.35B	11.46B	9.12B	13.98B	14.55B	12.35B	6.91B	5.42B	4.24B
Short-Term Investments	513M	816M	130M	3.24B	1.28B	3.05B	1.97B	1.39B	2.11B
Long-Term Investments	n/a	2.5B	2.19B	2.71B	4.51B	767M	1.77B	2.48B	2.72B
Other Long-Term Assets	6.42B	1.84B	1.04B	1.66B	2.08B	6.6B	-14.03B	1.53B	1.05B
Receivables	10.75B	15.26B	13.94B	12.52B	8.5B	7.68B	5.75B	6.3B	5.54B
Inventory	2.56B	2.66B	2.34B	2.1B	2.07B	4.29B	1.2B	1.17B	1.24B
Other Current Assets	5.62B	1.56B	1.74B	1.29B	3.79B	1.98B	1.12B	n/a	n/a
Total Current Assets	29.78B	31.77B	27.27B	33.26B	30.19B	29.35B	8.88B	14.85B	13.7B
Property-Plant & Equipment	7.14B	8.04B	7.47B	6.97B	6.75B	6.25B	5.03B	5B	4.98B
Goodwill & Intangibles	45.03B	48.24B	57.5B	63.28B	73.79B	86.46B	7.63B	8.07B	8.26B
Total Long-Term Assets	62.82B	63.39B	69.55B	76.05B	88.29B	100.59B	1.77B	18.7B	20B
Total Assets	92.6B	95.16B	96.82B	109.31B	118.48B	129.94B	10.66B	33.55B	33.71B
Account Payables	3.6B	3.26B	3.04B	2.95B	2.71B	2.44B	1.89B	2.25B	1.66B
Deferred Revenue	n/a	271M	1.34B	3.69B	3.62B	4.49B	172M	83M	762M
Short-Term Debt	2.05B	3.12B	4.26B	4.95B	2.34B	3.35B	1.7B	987M	992M
Other Current Liabilities	17.95B	13.06B	4.21B	3.87B	4.45B	4.41B	5.61B	5.11B	4.41B
Total Current Liabilities	23.77B	22.26B	21.89B	21.87B	19.08B	18.3B	1.7B	9.56B	8.84B
Long-Term Debt	47.6B	36.65B	35.06B	39.6B	48.34B	43.39B	5.65B	6.97B	5.72B
Other Long-Term Liabilities	3.1B	4.59B	5.05B	6.13B	6.59B	9.01B	4.09B	4.71B	2.26B
Total Long-Term Liabilities	52.44B	43.41B	43.81B	51.44B	61.52B	59.94B	5.65B	12.14B	8.52B
Total Liabilities	76.22B	65.67B	65.7B	73.31B	80.6B	78.25B	7.35B	21.7B	17.36B
Total Debt	51.2B	41.46B	40.72B	45.6B	51.67B	47.54B	7.35B	7.96B	6.71B
Common Stock	292M	292M	292M	292M	292M	292M	221M	221M	221M
Retained Earnings	14.91B	28.77B	25.5B	23.82B	21.28B	34.47B	34.06B	31.16B	33.51B
Comprehensive Income	-1.24B	-1.55B	-1.28B	-1.27B	-1.84B	-1.52B	-2.76B	-2.29B	-2.5B
Shareholders Equity	16.34B	29.43B	31.06B	35.95B	37.82B	51.6B	14.03B	11.74B	16.18B
Total Investments	513M	3.31B	2.32B	5.96B	5.79B	3.81B	3.75B	3.87B	4.83B